BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 18627642)

  • 21. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
    Hatanaka M; Grigera DE; Barbosa WL; Jordao M; Susanna R
    J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide. Dorzolamide-Timolol Combination Study Group.
    Clineschmidt CM; Williams RD; Snyder E; Adamsons IA
    Ophthalmology; 1998 Oct; 105(10):1952-9. PubMed ID: 9787369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.
    Nixon DR; Yan DB; Chartrand JP; Piemontesi RL; Simonyi S; Hollander DA
    Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A controlled clinical trial of dorzolamide: a single-centre subset of a multicentre study.
    Simpson AJ; Gray TB; Ballantyne C
    Aust N Z J Ophthalmol; 1996 Feb; 24(1):39-42. PubMed ID: 8743003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Michaud JE; Friren B;
    Am J Ophthalmol; 2001 Aug; 132(2):235-43. PubMed ID: 11476685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy and safety of dorzolamide as adjunctive therapy to timolol maleate gellan solution in patients with elevated intraocular pressure. Additivity Study Group.
    Adamsons I; Clineschmidt C; Polis A; Taylor J; Shedden A; Laibovitz R
    J Glaucoma; 1998 Aug; 7(4):253-60. PubMed ID: 9713783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Twenty-four hour control of intraocular pressure with dorzolamide and timolol maleate in exfoliation and primary open-angle glaucoma.
    Konstas AG; Maltezos A; Bufidis T; Hudgins AG; Stewart WC
    Eye (Lond); 2000 Feb; 14 ( Pt 1)():73-7. PubMed ID: 10755105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing the fixed combination dorzolamide-timolol (Cosopt) to concomitant administration of 2% dorzolamide (Trusopt) and 0.5% timolol -- a randomized controlled trial and a replacement study.
    Francis BA; Du LT; Berke S; Ehrenhaus M; Minckler DS;
    J Clin Pharm Ther; 2004 Aug; 29(4):375-80. PubMed ID: 15271105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and side effects of latanoprost monotherapy compared to adding dorzolamide to timolol in patients with glaucoma and ocular hypertension--a three-month randomised study. Spanish Latanoprost Study Group.
    García Sanchez J
    Eur J Ophthalmol; 2000; 10(3):198-204. PubMed ID: 11071026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Success rates for switching to dorzolamide/timolol fixed combination in timolol responders who are insufficiently controlled by latanoprost monotherapy.
    Sonty S; Henry JC; Sharpe ED; Weiss MJ; Stewart JA; Nelson LA; Stewart WC
    Acta Ophthalmol; 2008 Jun; 86(4):419-23. PubMed ID: 18039347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of dorzolamide/timolol-fixed combination versus bimatoprost in patients with open-angle glaucoma who are poorly controlled on latanoprost.
    Sharpe ED; Williams RD; Stewart JA; Nelson LA; Stewart WC
    J Ocul Pharmacol Ther; 2008 Aug; 24(4):408-13. PubMed ID: 18627340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the effects of 0.005% latanoprost and fixed combination dorzolamide/timolol on retrobulbar haemodynamics in previously untreated glaucoma patients.
    Martínez A; Sánchez M
    Curr Med Res Opin; 2006 Jan; 22(1):67-73. PubMed ID: 16393432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of bimatoprost 0.03% versus timolol maleate 0.5%/dorzolamide 2% fixed combination.
    Day DG; Sharpe ED; Beischel CJ; Jenkins JN; Stewart JA; Stewart WC
    Eur J Ophthalmol; 2005; 15(3):336-42. PubMed ID: 15945001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the effects of dorzolamide/timolol and latanoprost/timolol fixed combinations upon intraocular pressure and progression of visual field damage in primary open-angle glaucoma.
    Pajic B; Pajic-Eggspuehler B; Häfliger IO
    Curr Med Res Opin; 2010 Sep; 26(9):2213-9. PubMed ID: 20673200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group.
    Strahlman ER; Vogel R; Tipping R; Clineschmidt CM
    Ophthalmology; 1996 Aug; 103(8):1283-93. PubMed ID: 8764800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients].
    Kałuzny JJ; Szaflik J; Czechowicz-Janicka K; Kałuzny J; Orzałkiewicz A; Zaleska-Zmijewska A; Krajewska M; Stewart JA; Leech JN; Stewart WC
    Klin Oczna; 2004; 106(1-2 Suppl):241-2. PubMed ID: 15510513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerability and efficacy of dorzolamide versus acetazolamide added to timolol.
    Stewart WC; Halper LK; Johnson-Pratt L; Polis A; Hartenbaum D
    J Ocul Pharmacol Ther; 2002 Jun; 18(3):211-20. PubMed ID: 12099542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of latanoprost with fixed-combination dorzolamide and timolol in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label, parallel-group, multicenter study in Latin America.
    Susanna R; Sheu WP;
    Clin Ther; 2004 May; 26(5):755-68. PubMed ID: 15220019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between visual field severity and response to fixed combination dorzolamide/timolol or timolol alone.
    Olander KW; Galet VA; Jia G; Smugar SS; Stewart WC
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):357-64. PubMed ID: 19441888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of the dorzolamide/timolol fixed combination versus latanoprost in the treatment of ocular hypertension or glaucoma: combined analysis of pooled data from two large randomized observer and patient-masked studies.
    Fechtner RD; McCarroll KA; Lines CR; Adamsons IA
    J Ocul Pharmacol Ther; 2005 Jun; 21(3):242-9. PubMed ID: 15969642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.